Latest News in the pharma Industry

Market News

Gastrointestinal drugs market to hit $48.4 billion by 2022 as biologic products revolutionize the treatment space

Gastrointestinal drugs market to hit $48.4 billion by 2022 as biologic products revolutionize the treatment space

6 Oct 2016

Although the market has recently been hit by the patent expirations of a number of the leading gastrointestinal products, the approval of new drugs, as well as rising prevalence, are expected to drive considerable growth. says GBI Research.

Read more 
Lilly subsidiary to acquire Boehringer Ingelheim Vetmedica's US feline, canine and rabies vaccines portfolio

Lilly subsidiary to acquire Boehringer Ingelheim Vetmedica's US feline, canine and rabies vaccines portfolio

6 Oct 2016

Eight new product lines and a fully integrated manufacturing and R&D site to transfer to Elanco, adding to its growing companion animal business.

Read more 
Intas Pharmaceuticals acquires Actavis UK & Ireland generics businesses from Teva

Intas Pharmaceuticals acquires Actavis UK & Ireland generics businesses from Teva

6 Oct 2016

Transaction is part of the European Commission’s anti-trust divestiture requirements arising from Teva’s acquisition of Allergan’s generics business.

Read more 
Patent trial and appeal board upholds the validity of Lialda patent

Patent trial and appeal board upholds the validity of Lialda patent

6 Oct 2016

Shire pleased with the decision and will continue to vigorously defend its patents.

Read more